However, it is unclear whether these transcriptomic alterations and activated pathways of adaptive immunity are reflections of the intra-tumoral plasticity to the peripheral blood or if these modifications in circulating CD4+T-cells actually allow melanoma to differentiate, to resist and to metastasize. The gene discussed is CD4; the disease is melanoma.